Krystal Biotech, Inc. (KRYS)

261.41 +12.50 (+5.02%) USD  |  NASDAQ  |  Jan 09, 16:00
277.45 +16.04 (+6.14%) Pre-Market: 08:40
More

Krystal Biotech Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
DexCom, Inc. Upgrade
BioLife Solutions, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade